Nick joined Clearview in 2012. Prior to joining, he was an Associate focused on business development for Lee Antimicrobial, a private equity-backed portfolio company focused on combating hospital-acquired infections. He began his career as an Investment Banking Analyst at Barclays Capital. Nick holds an MBA in Finance and Economics from Columbia University and a BA in American Studies from Georgetown University.